Robert Babb
22Patents
5h-index
35Co-inventors
65Inventor score
Filing activity: Jan 6, 2006 → Sep 6, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10787501B1 | Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments | Emerging Cross-Sectional Technologies | 32 | Active |
| US7771997B2 | Enhanced expression and stability regions | Chemistry; Metallurgy | 28 | Active |
| US7904892B2 | Systems and methods for identifying and displaying dependencies | Physics | 21 | Active |
| US10954289B1 | Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments | Emerging Cross-Sectional Technologies | 12 | Active |
| US8389239B2 | Enhanced expression and stability regions | Chemistry; Metallurgy | 9 | Active |
| US10975139B1 | Anti-SARS-CoV-2-Spike glycoprotein antibodies and antigen-binding fragments | Emerging Cross-Sectional Technologies | 4 | Active |
| US9222106B2 | Enhanced expression and stability regions | Chemistry; Metallurgy | 3 | Active |
| US10752698B2 | Method for generating high affinity antibodies | Chemistry; Metallurgy | 1 | Active |
| US11787867B2 | Anti-GITR antibodies and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US11732030B2 | Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments | Emerging Cross-Sectional Technologies | 1 | Active |
| US9562238B2 | Enhanced expression and stability regions | Chemistry; Metallurgy | 1 | Active |
| US11111314B2 | Non-human animals that select for light chain variable regions that bind antigen | Chemistry; Metallurgy | 0 | Active |
| US11530277B2 | Compositions and methods for making antibodies based on use of an expression-enhancing locus | Chemistry; Metallurgy | 0 | Active |
| US11808766B2 | Method for generating high affinity antibodies | Chemistry; Metallurgy | 0 | Active |
| US12371487B2 | Methods for obtaining antibodies that bind transmembrane proteins and cells that produce the same | Chemistry; Metallurgy | 0 | Active |
| US9932605B2 | Enhanced expression and stability regions | Chemistry; Metallurgy | 0 | Active |
| US10415055B2 | Enhanced expression and stability regions | Chemistry; Metallurgy | 0 | Active |
| US12331127B2 | Therapeutic uses of anti-GITR antibodies | Chemistry; Metallurgy | 0 | Active |
| US11142578B2 | Anti-MET antibodies, bispecific antigen binding molecules that bind MET, and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US12251440B2 | Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments | Emerging Cross-Sectional Technologies | 0 | Active |
| US10787522B2 | VL antigen binding proteins exhibiting distinct binding characteristics | Chemistry; Metallurgy | 0 | Active |
| US11512144B2 | Compositions and methods for making antibodies based on use of an expression-enhancing loci | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.